Northwell Holdings, the venture investment arm of Northwell Health, leads investment round in Nova Leah, a first-of-its-kind cybersecurity platform aimed at protecting connected medical devices from threats. 

[December 7th, 2021]: Northwell Holdings, the venture investment arm of Northwell Health, has invested in Nova Leah, a leading cybersecurity technology company with offices in Boston and Dundalk, Ireland. The investment was led by Northwell Holdings and supported by a number of other investors. Nova Leah was founded by Dr. Anita Finnegan, international government advisor and award-winning expert in cybersecurity risk management.

“Nova Leah is one of the most exciting companies within the fast-growing sector of cybersecurity for connected medical devices,” said Rich Mulry, president and CEO of Northwell Holdings & Ventures. “We believe Northwell’s investment and expertise will support Nova Leah’s expansion into health care provider markets.”

Nova Leah’s customers include many of the world’s top medical device manufacturers. Its award-winning cloud-based security product SelectEvidence® ensures that connected medical devices are continuously assessed for cybersecurity vulnerabilities.

The investment is timed to support Nova Leah in expanding its technology footprint across the US, bringing its real-time threat monitoring product portfolio into health care delivery systems. The move is a response to the significant and growing disruptions that healthcare delivery systems have experienced as a result of a variety of security threats, which have hampered their ability to function effectively. Nova Leah supports cybersecurity processes across medical device design and development, market approval, monitoring, supply chain, purchasing, deployment, and use right through to product decommissioning. 

Anita Finnegan, PhD, founder and CEO of Nova Leah welcomed the news. “Northwell Health has an outstanding reputation for both market innovation and patient safety. We are excited to collaborate with Northwell Health to apply our product IP to the health care delivery market in New York and beyond. This investment will have a significant impact on our ability to enter new markets and scale effectively.” 

###ENDS ###

Notes to Editors 

About Nova Leah

Nova Leah is a world leader in the provision of cybersecurity solutions for medical device manufacturers and healthcare providers. With offices in the US and in Ireland, Nova Leah’s software helps connected medical device manufacturers meet cybersecurity compliance requirements throughout the entire product lifecycle. Nova Leah’s flagship product, SelectEvidence® is an expert cybersecurity risk assessment platform that guides medical device manufacturers through the processes of identifying applicable threats to their products and implementing the right security controls to mitigate them.

Nova Leah was founded by Dr. Anita Finnegan, government advisor and award-winning international expert in cybersecurity risk management. Finnegan is a published author and project leader of multiple, internationally regulated, industry standards for medical equipment in healthcare technology. For more information go to   

About Northwell Holdings

Northwell Holdings is the venture investment arm of Northwell Health, investing in companies that are strategically synergistic with its parent. The Holdings mandate provides for investment capital and health system expertise/access to emerging companies that support the overarching mission of advancing patient care.  Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians.  

Northwell Holdings focuses its efforts on building new technologies and progressing new ideas in both clinical and non-clinical areas in the health care sector. The team has deep experience with entrepreneurial ventures, from venture creation and investing in early-stage companies to providing strategic and advisory services to its portfolio companies.